De novo DNA methylation is required to restrict T helper lineage plasticity.

PubWeight™: 0.94‹?›

🔗 View Article (PMC 3391093)

Published in J Biol Chem on May 14, 2012

Authors

Rajan M Thomas1, Christopher J Gamper, Brian H Ladle, Jonathan D Powell, Andrew D Wells

Author Affiliations

1: Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine and The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA.

Articles citing this

T-cell memory differentiation: insights from transcriptional signatures and epigenetics. Immunology (2013) 1.29

Global DNA methylation remodeling accompanies CD8 T cell effector function. J Immunol (2013) 1.27

Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease. Nat Rev Immunol (2016) 1.15

Memory T follicular helper CD4 T cells. Front Immunol (2015) 1.06

Molecular determinants of regulatory T cell development: the essential roles of epigenetic changes. Front Immunol (2013) 0.98

Epigenetic Activation and Silencing of the Gene that Encodes IFN-γ. Front Immunol (2013) 0.94

Recent thymic emigrants and mature naive T cells exhibit differential DNA methylation at key cytokine loci. J Immunol (2013) 0.92

STAT4 and T-bet are required for the plasticity of IFN-γ expression across Th2 ontogeny and influence changes in Ifng promoter DNA methylation. J Immunol (2013) 0.85

Opposing roles of STAT4 and Dnmt3a in Th1 gene regulation. J Immunol (2013) 0.85

Helper T cell plasticity: impact of extrinsic and intrinsic signals on transcriptomes and epigenomes. Curr Top Microbiol Immunol (2014) 0.80

Azacytidine treatment inhibits the progression of Herpes Stromal Keratitis by enhancing regulatory T cell function. J Virol (2017) 0.79

De novo DNA methylation by DNA methyltransferase 3a controls early effector CD8+ T-cell fate decisions following activation. Proc Natl Acad Sci U S A (2016) 0.79

Human memory CD8 T cell effector potential is epigenetically preserved during in vivo homeostasis. J Exp Med (2017) 0.77

Genomics of lymphoid malignancies reveal major activation pathways in lymphocytes. J Autoimmun (2013) 0.75

Epipolymorphisms associated with the clinical outcome of autoimmune arthritis affect CD4+ T cell activation pathways. Proc Natl Acad Sci U S A (2016) 0.75

TET Methylcytosine Oxidases in T Cell and B Cell Development and Function. Front Immunol (2017) 0.75

Articles cited by this

A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell (2006) 48.80

Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature (2008) 30.29

Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature (2006) 25.90

DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell (1999) 25.75

Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet (2009) 12.08

Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity (2009) 9.73

A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity (2001) 9.45

Late developmental plasticity in the T helper 17 lineage. Immunity (2009) 8.81

Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet (1998) 7.52

Fate mapping of IL-17-producing T cells in inflammatory responses. Nat Immunol (2011) 5.98

Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest (2009) 4.74

An epigenetic view of helper T cell differentiation. Nat Immunol (2003) 3.87

Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity (2001) 3.84

Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J Exp Med (1996) 3.41

Hlx is induced by and genetically interacts with T-bet to promote heritable T(H)1 gene induction. Nat Immunol (2002) 2.87

Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions. Immunity (2010) 2.59

Structural basis for recognition of H3K4 methylation status by the DNA methyltransferase 3A ATRX-DNMT3-DNMT3L domain. EMBO Rep (2009) 2.50

Inhibition of IFN-gamma transcription by site-specific methylation during T helper cell development. EMBO J (2006) 2.21

Independent and epigenetic regulation of the interleukin-4 alleles in CD4+ T cells. Science (1998) 2.13

DNA methylation dictates histone H3K4 methylation. Mol Cell Biol (2007) 1.96

Differentiation of the T helper phenotypes by analysis of the methylation state of the IFN-gamma gene. J Immunol (1994) 1.52

Signals from CD28 induce stable epigenetic modification of the IL-2 promoter. J Immunol (2005) 1.52

The proximal regulatory element of the interferon-gamma promoter mediates selective expression in T cells. J Biol Chem (1996) 1.46

Identification of DNA methyltransferase 3a as a T cell receptor-induced regulator of Th1 and Th2 differentiation. J Immunol (2009) 1.45

Role of DNA methylation in stable gene repression. J Biol Chem (2007) 1.45

Molecular coupling of DNA methylation and histone methylation. Epigenomics (2010) 1.43

DNA methylation is a nonredundant repressor of the Th2 effector program. J Immunol (2004) 1.34

A distinct region of the murine IFN-gamma promoter is hypomethylated from early T cell development through mature naive and Th1 cell differentiation, but is hypermethylated in Th2 cells. J Immunol (2004) 1.26

Histone tails regulate DNA methylation by allosterically activating de novo methyltransferase. Cell Res (2011) 1.24

T-bet antagonizes mSin3a recruitment and transactivates a fully methylated IFN-gamma promoter via a conserved T-box half-site. Proc Natl Acad Sci U S A (2005) 1.22

Human Th1 and Th17 cells exhibit epigenetic stability at signature cytokine and transcription factor loci. J Immunol (2011) 1.17

Long-range regulation of cytokine gene expression. Curr Opin Immunol (2008) 1.01

Superantigen-induced CD4+ T cell tolerance is associated with DNA methylation and histone hypo-acetylation at cytokine gene loci. Genes Immun (2007) 0.95

T-bet dependent removal of Sin3A-histone deacetylase complexes at the Ifng locus drives Th1 differentiation. J Immunol (2008) 0.94

Articles by these authors

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant (2008) 7.10

The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity (2009) 6.86

Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med (2007) 6.61

The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat Immunol (2011) 5.22

Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med (2009) 4.59

Role of LAG-3 in regulatory T cells. Immunity (2004) 4.36

Egr-2 and Egr-3 are negative regulators of T cell activation. Nat Immunol (2005) 3.74

Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol (2006) 3.32

Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response. J Exp Med (2005) 3.22

Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med (2005) 3.17

HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease. Blood (2012) 2.72

A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood (2007) 2.69

A role for mammalian target of rapamycin in regulating T cell activation versus anergy. J Immunol (2007) 2.53

Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome. Biol Blood Marrow Transplant (2010) 2.17

Anergic T cells are metabolically anergic. J Immunol (2009) 2.12

The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo. J Exp Med (2005) 2.09

High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease. Blood (2010) 1.99

Notch signaling augments T cell responsiveness by enhancing CD25 expression. J Immunol (2003) 1.95

Epigenetic remodeling of the IL-2 and IFN-gamma loci in memory CD8 T cells is influenced by CD4 T cells. J Immunol (2006) 1.88

Estrogen-related receptor-α is a metabolic regulator of effector T-cell activation and differentiation. Proc Natl Acad Sci U S A (2011) 1.86

Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation. J Biol Chem (2006) 1.84

mTOR, metabolism, and the regulation of T-cell differentiation and function. Immunol Rev (2012) 1.74

The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation. Immunity (2010) 1.64

Ikaros enforces the costimulatory requirement for IL2 gene expression and is required for anergy induction in CD4+ T lymphocytes. J Immunol (2007) 1.61

Impaired T cell function in RANTES-deficient mice. Clin Immunol (2002) 1.60

A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity. Immunity (2011) 1.58

OX40 costimulation synergizes with GM-CSF whole-cell vaccination to overcome established CD8+ T cell tolerance to an endogenous tumor antigen. J Immunol (2006) 1.53

Signals from CD28 induce stable epigenetic modification of the IL-2 promoter. J Immunol (2005) 1.52

Identification of DNA methyltransferase 3a as a T cell receptor-induced regulator of Th1 and Th2 differentiation. J Immunol (2009) 1.45

BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses. Eur J Immunol (2004) 1.44

mTOR: taking cues from the immune microenvironment. Immunology (2009) 1.38

Defective activation of protein kinase C and Ras-ERK pathways limits IL-2 production and proliferation by CD4+CD25+ regulatory T cells. J Immunol (2006) 1.37

Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3. Eur J Immunol (2008) 1.35

B7-H3 promotes acute and chronic allograft rejection. Eur J Immunol (2005) 1.31

mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation. J Clin Invest (2015) 1.18

Cutting edge: chromatin remodeling as a molecular basis for the enhanced functionality of memory CD8 T cells. J Immunol (2008) 1.16

Enhancement of tumor immunotherapy by deletion of the A2A adenosine receptor. Cancer Immunol Immunother (2011) 1.16

Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism. J Immunol (2003) 1.15

Structural and biological features of FOXP3 dimerization relevant to regulatory T cell function. Cell Rep (2012) 1.14

Retracted Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways. Nat Immunol (2013) 1.09

Mammalian target of rapamycin integrates diverse inputs to guide the outcome of antigen recognition in T cells. J Immunol (2012) 1.08

The novel cyclophilin binding compound, sanglifehrin A, disassociates G1 cell cycle arrest from tolerance induction. J Immunol (2004) 1.08

Disruption of Id1 reveals major differences in angiogenesis between transplanted and autochthonous tumors. Cancer Cell (2003) 1.08

Modulation of Kv channel expression and function by TCR and costimulatory signals during peripheral CD4(+) lymphocyte differentiation. J Exp Med (2002) 1.07

Ikaros silences T-bet expression and interferon-gamma production during T helper 2 differentiation. J Biol Chem (2009) 1.05

Opposing roles for the cyclin-dependent kinase inhibitor p27kip1 in the control of CD4+ T cell proliferation and effector function. J Immunol (2005) 1.05

Comparative analysis of E2F family member oncogenic activity. PLoS One (2007) 1.04

The role of cyclin-dependent kinases in T-cell development, proliferation, and function. Crit Rev Immunol (2006) 0.98

Enhanced interaction between Hsp90 and raptor regulates mTOR signaling upon T cell activation. Mol Immunol (2009) 0.98

Cutting Edge: TCR-induced NAB2 enhances T cell function by coactivating IL-2 transcription. J Immunol (2006) 0.98

Foxp3 processing by proprotein convertases and control of regulatory T cell function. J Biol Chem (2008) 0.97

Anti-oxidant inhibition of hyaluronan fragment-induced inflammatory gene expression. J Inflamm (Lond) (2008) 0.96

Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse. Blood (2007) 0.96

PI3K/mTOR signaling regulates prostatic branching morphogenesis. Dev Biol (2011) 0.96

Differential regulation of hyaluronan-induced IL-8 and IP-10 in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol (2006) 0.96

The adenosine a2a receptor inhibits matrix-induced inflammation in a novel fashion. Am J Respir Cell Mol Biol (2008) 0.95

Foxp3 protein stability is regulated by cyclin-dependent kinase 2. J Biol Chem (2013) 0.95

Incomplete activation of CD4 T cells by antigen-presenting transitional immature B cells: implications for peripheral B and T cell responsiveness. J Immunol (2003) 0.93

Conserved intergenic elements and DNA methylation cooperate to regulate transcription at the il17 locus. J Biol Chem (2012) 0.93

FOXP3 inhibits activation-induced NFAT2 expression in T cells thereby limiting effector cytokine expression. J Immunol (2009) 0.93

Mbd2 promotes foxp3 demethylation and T-regulatory-cell function. Mol Cell Biol (2013) 0.92

Pulmonary vaccination as a novel treatment for lung fibrosis. PLoS One (2012) 0.91

All PI3Kinase signaling is not mTOR: dissecting mTOR-dependent and independent signaling pathways in T cells. Front Immunol (2012) 0.91

The cyclin-dependent kinase inhibitor p27kip1 is required for transplantation tolerance induced by costimulatory blockade. J Immunol (2006) 0.91

Sprouty-2 regulates HIV-specific T cell polyfunctionality. J Clin Invest (2014) 0.90

Insight into the role of mTOR and metabolism in T cells reveals new potential approaches to preventing graft rejection. Curr Opin Organ Transplant (2014) 0.89

Mechanism of T cell-mediated endothelial apoptosis. Transplantation (2002) 0.89

Hyaluronan fragments induce IFNβ via a novel TLR4-TRIF-TBK1-IRF3-dependent pathway. J Inflamm (Lond) (2013) 0.89

Histone deacetylase inhibitors and transplantation. Curr Opin Immunol (2007) 0.87

Sensing the immune microenvironment to coordinate T cell metabolism, differentiation & function. Semin Immunol (2013) 0.87

Adenosine and anergy. Autoimmunity (2007) 0.86

Cyclin-dependent kinase 2 controls peripheral immune tolerance. J Immunol (2012) 0.86

Genome-wide analyses of ChIP-Seq derived FOXA2 DNA occupancy in liver points to genetic networks underpinning multiple complex traits. J Clin Endocrinol Metab (2014) 0.84

Hyaluronan fragments promote inflammation by down-regulating the anti-inflammatory A2a receptor. Am J Respir Cell Mol Biol (2011) 0.83

NF-kappa B activation mediates the cross-talk between extracellular matrix and interferon-gamma (IFN-gamma) leading to enhanced monokine induced by IFN-gamma (MIG) expression in macrophages. J Biol Chem (2002) 0.82

Quieting T cells with Slfn2. Nat Immunol (2010) 0.81

A ChIP-seq-defined genome-wide map of MEF2C binding reveals inflammatory pathways associated with its role in bone density determination. Calcif Tissue Int (2013) 0.80

An Fc domain protein-small molecule conjugate as an enhanced immunomodulator. J Am Chem Soc (2014) 0.80

Genetic and biochemical regulation of CD4 T cell effector differentiation: insights from examination of T cell clonal anergy. Immunol Res (2010) 0.80

CD8⁺ Foxp3⁺ tumor infiltrating lymphocytes accumulate in the context of an effective anti-tumor response. Int J Cancer (2010) 0.80

Exploring functional in vivo consequences of the selective genetic ablation of mTOR signaling in T helper lymphocytes. Methods Mol Biol (2012) 0.79

Regulation of CD4⁺ and CD8⁺ effector responses by Sprouty-1. PLoS One (2012) 0.78

Selective activation of antigen-experienced T cells by anti-CD3 constrained on nanoparticles. J Immunol (2013) 0.77

Slc7a5 helps T cells get with the program. Nat Immunol (2013) 0.77

Interleukin-2-mediated survival and proliferative signals are uncoupled in T lymphocytes that fail to divide after activation. Am J Transplant (2002) 0.76

Targeted immunosuppression: no longer naïve. Clin Immunol (2011) 0.75